Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Licartin after TACE for unresectable hepatocellular carcinoma
ChiCTR-TRC-09000564Phase 4Completed
- Sponsor
- Air Force Medical University
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of licofelone in hepatocellular carcinoma (HCC) (2 arms), sponsored by Air Force Medical University. Primary endpoints: Overall survival and Recurrence. Started Oct 2009; status: completed.
02
Drugs
licofelone
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on ChiCTR-TRC-09000564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000564.